Navigation Links
Misleading anti-malarial drug

Promotional claims about the preventive efficacy of a malaria drug are being questioned by experts, who say the statements are misleading and should be withdrawn. Manufacturer GlaxoSmithKline markets the anti-malarial drug Malarone (atovaquone and proguanil) as being 97 per cent effective at preventing the aggressive falciparum strain of malaria, but the Drug and Therapeutics Bulletin (DTB) – published by the Consumers’ Association – says the evidence for this is misleading. //

DTB says that no study has been published into the drug’s effectiveness as a malaria preventative in non-immune populations from countries such as the UK where the disease is not endemic. The publication warns that it is not known if Malarone is as effective as the previous main choices – mefloquine and doxycycline.

Professor Joe Collier, editor of Drug and Therapeutics Bulletin, said the lack of published evidence in non-immune travellers meant there was nothing to support the manufacturer’s promotional claim about Malarone’s effectiveness and that the claim should be withdrawn as a result. A spokesperson for GlaxoSmithKline said the company supported the 97 per cent efficacy rate indicated by the three efficacy trials carried out in Africa.
>
'"/>




Page: 1

Related medicine news :

1. Misleading Advertisements for Prescription Drugs
2. The Effects Of Smoking Misleading
3. Lifting The Screen off Misleading Sunscreen labels
4. Misleading Health Claims On Food Labels No Longer Allowed in EU
5. Walkers Crisps Advertisements make Misleading Claims about Salt Content
6. Medical Council Of India Draws Public Attention on Misleading Ads.
7. Obesity Drug Advertisements Misleading Teens
8. Labeling of Dairy Products with Trans fat labels, Misleading to Consumers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... 001 and its sugar-free alternative VW+ 002. The drinks have been produced in ... optimal conditions to perform during your workout. , After a successful launch in ...
(Date:1/20/2017)... ... , ... “The Angel”: a heartwarming and earnest tale of faith and ... children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional ... writer. , When asked of her new book, Marjorie says, “‘The Angel’ was written ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “I Forgive You”: a fine examination ... “I Forgive You” is the creation of published author, Stephen Miller, who, for over ten ... has gracefully given to him. Born in Trinidad and Tobago, he has been serving the ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: ... published author, Sara Seymour, who lives in Lafayette, Indiana where she works in a ... iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book ...
(Date:1/20/2017)... ... ... is God’s Lighthouse”: a moving and colorful collection of prayers that reminds readers ... author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published works ... school and have many different titles,” Gaapf mentions about his different works. “I am ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, a ... ("KemPharm" or the "Company") (NASDAQ: KMPH ) of ... and certain officers and directors and underwriters of the Company,s ... the role of lead plaintiff. The lawsuit has ... Court for Johnson County on behalf ...
(Date:1/20/2017)... Research and Markets has announced the ... Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis ... ... Aids Market Sales Volume, Company Analysis and Forecast to 2022 ... industry. The growing prevalence of hearing impairment coupled ...
(Date:1/20/2017)... Stock-Callers.com today evaluates the following Drug Manufacturers equities: ... A/S (NYSE: NVO ), Sucampo Pharmaceuticals Inc. (NASDAQ: ... PTX ). These stocks belong to the Healthcare ... finishing near its session lows. As per a NASDAQ report, ... of health care companies in the S&P 500 also were ...
Breaking Medicine Technology: